Case series that describes disseminated BCG disease in five immunocompromised infants following BCG vaccination. It highlights the safety risks of BCG vaccination in infants with undiagnosed immunodeficiency and the importance of identifying the high-risk infants before vaccination. The findings are particularly relevant to national BCG vaccination policy and the safe implementation of TB vaccination programmes